State-funded ISCRM Fellowships enable students at the undergraduate, graduate, and postdoctoral level to advance research efforts aimed at addressing the root causes of diseases. Read More
The FDA has approved a first-ever gene therapy for Duchenne muscular dystrophy based in part on technology developed by UW Medicine/ISCRM Researchers Read More
Cole DeForest, Ronald Young Kwon, Feini (Sylvia) Qu, and Meredith Redd have received the 2023 ISCRM Innovation Pilot Awards. Read More
Julie Mathieu, PhD and Niclas Bengtsson, PhD have received prestigious awards from the John H. Tietze Foundation Trust that will help fuel promising research underway in their labs. Read More
New research from the Moltke Lab at UW Medicine describes how our body generates an enigmatic cell type, known as tuft cells, that detects parasitic worms and helps to mobilize an immune response. Read More
Light-activation technology developed by the Cole DeForest Research Group has potential applications in tissue engineering, regenerative medicine, and understanding how the body works. Read More
Cory Simpson, MD, PhD and Andre Berndt, PhD detail how advances in biosensor and optogenetic technology are opening up new possibilities in dermatology research. Read More
Researchers in the Murry Lab have demonstrated that a quadruple gene editing approach safely suppresses irregular heartbeats in stem cell therapy for injured hearts. Read More
Tiara Schwarze-Taufiq, an ISCRM undergraduate fellow in 2021, is now a Research Scientist in the Young Lab thanks to an NIH R21 grant made possible in part by her own research. Read More
Research from the DeForest and Davis Labs describes a new method for cell extraction using engineered versions of an enzyme called sortase that have evolved to recognize and break specific peptide sequences. Read More
